7 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... suspension 400 mg PO BID ... mucosal #IDSA #Prevention ... #Treatment #management ... #opportunistic
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
Recommendations for Preventing ... Alternative Management ... agents may be used ... 500–1000 mg PO BID ... #opportunistic
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Prophylaxis: • If used ... for 3 days, then BID ... with ARV (see Table ... #Treatment #management ... #opportunistic
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
emphasis placed on prevention ... then placed on prevention ... #diagnosis #differential ... #algorithm #management ... cardiology #treatment #table
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Differential Diagnosis ... Management during ... Delivery • Stable ... Avoid ARBs • ICD ... months before 1° prevention
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Clarithromycin 500 mg PO BID ... please refer to Table ... recommendation when used ... #Treatment #management ... #opportunistic
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Please refer to the table ... ARV drugs when used ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management ... #opportunistic